Seo Hyun-Nam, Seo Jin-Ho, Lee Cheol-Young, Song Jihye, Kim Jong-Hyun, Kim Hyun-Woo
Department of Neurosurgery, Konyang University Hospital, Daejeon, Korea.
Brain Tumor Res Treat. 2017 Apr;5(1):45-48. doi: 10.14791/btrt.2017.5.1.45. Epub 2017 Apr 30.
Anaplastic large T-cell lymphoma (ALCL) encompasses different clinical entities that can be aggressive or localized. Scalp anaplastic lymphoma kinase (ALK)-negative ALCL is considered a localized lymphoma, and usually extends to the regional lymph nodes; intracranial invasion is rare. A 74-year-old woman was diagnosed with scalp ALK-negative ALCL, but did not exhibit invasion of the lymph nodes. Computed tomography and magnetic resonance imaging revealed intracranial masses with bony erosions. We treated the patient using CHOP chemotherapy and achieved short-term regression of the scalp and intracranial lesions. However, the patients ultimately died of pneumonia during the pancytopenic period. Therefore, caution must be exercised when treating scalp ALK-negative ALCL with intracranial invasion.
间变性大T细胞淋巴瘤(ALCL)包括不同的临床实体,可为侵袭性或局限性。头皮间变性淋巴瘤激酶(ALK)阴性的ALCL被认为是局限性淋巴瘤,通常会扩散至区域淋巴结;颅内侵犯罕见。一名74岁女性被诊断为头皮ALK阴性的ALCL,但未出现淋巴结侵犯。计算机断层扫描和磁共振成像显示颅内肿块伴有骨质侵蚀。我们使用CHOP化疗对该患者进行治疗,头皮和颅内病变实现了短期消退。然而,患者最终在全血细胞减少期死于肺炎。因此,在治疗伴有颅内侵犯的头皮ALK阴性ALCL时必须谨慎。